Clinical Trials Directory

Trials / Completed

CompletedNCT01748942

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

A Randomized, Placebo Controlled, Double Blinded Study of Corticosteroid Treatment for the Reduction of Postoperative Pain Following Transoral Robotic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized pilot clinical trial studies dexamethasone in reducing oral pain and dry mouth after surgery in patients with oropharyngeal cancer. Dexamethasone may help lower pain and dry mouth caused by surgery.

Detailed description

PRIMARY OBJECTIVES: I. To prospectively determine if a longer 4-day course of dexamethasone (or equivalent) for the management of postoperative pain and dysphagia following transoral robotic surgery (TORS) is superior to the current standard of a single injection of dexamethasone 10 mg. SECONDARY OBJECTIVES: I. Determine the effect of postoperative corticosteroids on postoperative dysphagia following TORS. II. Determine the effect of postoperative corticosteroids on length of hospital stay following TORS. III. Determine the complications associated with postoperative corticosteroid use after TORS. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients receive dexamethasone intravenously (IV) at the time of surgery and orally (PO) every 8 hours for up to 4 days following surgery. ARM II: Patients receive dexamethasone IV at the time of surgery and placebo PO every 8 hours for up to 4 days following surgery. After completion of study treatment, patients are followed up for up to 12 months.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneGiven IV
DRUGDexamethasoneGiven PO
OTHERPlaceboGiven PO
PROCEDUREQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
PROCEDURETransoral Robotic SurgeryUndergo TORS

Timeline

Start date
2012-12-01
Primary completion
2016-07-01
Completion
2017-03-29
First posted
2012-12-13
Last updated
2018-06-19
Results posted
2017-09-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01748942. Inclusion in this directory is not an endorsement.